Hope for Alzheimer’s patients, families
Is hope of reversing Alzheimer’s Disease possible? Betty and Gary Lortscher of Bern say “Yes!”
On June 6, 1997, Betty’s brother, Dave, at the age of 65, died of early onset Alzheimer’s Disease (AD). At that time, Betty collected blood samples from herself and her parents, and had them sent to NCRAD, Indiana University for research purposes. Ever since, Betty was hoping a cure for AD could be found.
In 2009 and 2010, Betty’s Mini-Mental State Examination (MMSE) indicated dementia, after which her MMSE started a downward trend, which meant her AD was becoming more severe. The lowest MMSE scores were 16/30 as determined at Kansas University Alzheimer’s Disease Center (KU ADC) on Oct. 13, 2016, and again on Jan. 26, 2017.
Betty has participated in various AD studies and trials, including for the drug verubecestat. On a whim, I spoke with Dr. Frank Lyons, Kansas Regenerative Medicine Center of Manhattan, an affiliate of the California Stem Cell Treatment Center (CSCTC), about stem cell therapy. This ended up leading to a meeting with Dr. Christopher Duma, brain and spine surgeon in California, and subsequently beginning stem cell treatment. These treatments have included visits to California every two months. This procedure is FDA sanctioned but not FDA approved.
On May 16, 2017, Betty’s MMSE score increased. It increased another point on Nov. 16, 2017. According to Dr. Duma, statistically speaking Betty would have been in an Alzheimer’s facility by this point had she not received the stem cell injections.
We think Betty is demonstrating a potential procedure for reversing AD. We also think Betty’s brother is looking down and saying, “Good job, sis!”
Contact me with questions or for more information, at 785-336-3003 or GaryL@Lasibern.com.